Page last updated: 2024-08-23

tobramycin and Otitis Media

tobramycin has been researched along with Otitis Media in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (40.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Paterson, S	1
Kim, SY; Lee, HS; Park, MH; Roh, EY	1
Daschner, F	1
Ben-David, J; Brodsky, A; Fradis, M; Larboni, J; Podoshin, L; Srugo, I	1
Federspil, P	1

Trials

1 trial(s) available for tobramycin and Otitis Media

Article	Year
Chronic otitis media treated topically with ciprofloxacin or tobramycin. Archives of otolaryngology--head & neck surgery, 1997, Volume: 123, Issue:10 Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Double-Blind Method; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Otitis Media; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome	1997

Article

Year

Chronic otitis media treated topically with ciprofloxacin or tobramycin.

Archives of otolaryngology--head & neck surgery, 1997, Volume: 123, Issue:10

Topics: Administration, Topical; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Double-Blind Method; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Otitis Media; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome

1997

Other Studies

4 other study(ies) available for tobramycin and Otitis Media

Article	Year
Brainstem auditory evoked responses in 37 dogs with otitis media before and after topical therapy. The Journal of small animal practice, 2018, Volume: 59, Issue:1 Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Dogs; Ear, Middle; Evoked Potentials, Auditory, Brain Stem; Fluoroquinolones; Gentamicins; Hearing Loss; Otitis Media; Ticarcillin; Tobramycin	2018
Difference of Type 3 secretion system (T3SS) effector gene genotypes (exoU and exoS) and its implication to antibiotics resistances in isolates of Pseudomonas aeruginosa from chronic otitis media. Auris, nasus, larynx, 2017, Volume: 44, Issue:3 Topics: ADP Ribose Transferases; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Chaperonin 60; Chronic Disease; Ciprofloxacin; Drug Resistance, Bacterial; Female; Genotype; Glucosyltransferases; GTPase-Activating Proteins; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Otitis Media; Pseudomonas aeruginosa; Pseudomonas Infections; Reverse Transcriptase Polymerase Chain Reaction; Tobramycin; Type III Secretion Systems; Virulence Factors	2017
[Otitis media in a diabetic patient]. MMW, Munchener medizinische Wochenschrift, 1980, Jan-25, Volume: 122, Issue:4 Topics: Anti-Bacterial Agents; Diabetes Complications; Female; Humans; Middle Aged; Otitis Media; Pseudomonas aeruginosa; Tobramycin	1980
[Ototoxicity of the aminoglycoside antibiotics (author's transl)]. Infection, 1976, Volume: 4, Issue:4 Topics: Acid Phosphatase; Alkaline Phosphatase; Amikacin; Animals; Anti-Bacterial Agents; Child; Ear, Inner; Esterases; Ethacrynic Acid; Gentamicins; Guinea Pigs; Humans; Kidney Diseases; Noise; Otitis Media; Sisomicin; Sulfhydryl Compounds; Tobramycin	1976